Bright Minds Biosciences Statistics

Total Valuation

DRUG has a market cap or net worth of $263.57 million. The enterprise value is $259.66 million.

Market Cap	263.57M
Enterprise Value	259.66M

Important Dates

The last earnings date was Tuesday, December 31, 2024, before market open.

Earnings Date	Dec 31, 2024
Ex-Dividend Date	n/a

Share Statistics

DRUG has 6.99 million shares outstanding. The number of shares has increased by 15.87% in one year.

Current Share Class	6.99M
Shares Outstanding	6.99M
Shares Change (YoY)	+15.87%
Shares Change (QoQ)	-3.75%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	2.50M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	64.32
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.32, with a Debt / Equity ratio of 0.02.

Current Ratio	11.32
Quick Ratio	10.91
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-292.54

Financial Efficiency

Return on equity (ROE) is -46.18% and return on invested capital (ROIC) is -26.53%.

Return on Equity (ROE)	-46.18%
Return on Assets (ROA)	-25.19%
Return on Capital (ROIC)	-26.53%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1,786.15% in the last 52 weeks. The beta is 1.13, so DRUG's price volatility has been higher than the market average.

Beta (5Y)	1.13
52-Week Price Change	+1,786.15%
50-Day Moving Average	40.00
200-Day Moving Average	14.08
Relative Strength Index (RSI)	46.15
Average Volume (20 Days)	79,346

Short Selling Information

The latest short interest is 176,685, so 2.53% of the outstanding shares have been sold short.

Short Interest	176,685
Short Previous Month	221,224
Short % of Shares Out	2.53%
Short % of Float	7.08%
Short Ratio (days to cover)	1.24

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-1.94M
Pretax Income	-3.82M
Net Income	-2.07M
EBITDA	n/a
EBIT	-1.94M
Earnings Per Share (EPS)	-$0.48

Full Income Statement

Balance Sheet

The company has $4.23 million in cash and $88,057 in debt, giving a net cash position of $4.15 million or $0.59 per share.

Cash & Cash Equivalents	4.23M
Total Debt	88,057
Net Cash	4.15M
Net Cash Per Share	$0.59
Equity (Book Value)	4.10M
Book Value Per Share	0.91
Working Capital	4.04M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-1.37M
Capital Expenditures	n/a
Free Cash Flow	-1.28M
FCF Per Share	-$0.18

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DRUG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.87%
Shareholder Yield	-15.87%
Earnings Yield	-0.79%
FCF Yield	-0.48%

Analyst Forecast

The average price target for DRUG is $80.00, which is 117.51% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$80.00
Price Target Difference	117.51%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on July 14, 2023. It was a reverse split with a ratio of 0.2:1.

Last Split Date	Jul 14, 2023
Split Type	Reverse
Split Ratio	0.2:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1